Bank of New York Mellon
AUXL

Bank of New York Mellon’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bank of New York Mellon’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-265,268
Closed -$9.12M – 4336
2014
Q4 		$9.12M Sell
265,268
-79,506
-23% -$2.59M ﹤0.01% 1971
2014
Q3 		$10.3M Sell
344,774
-899
-0.3% -$19.1K ﹤0.01% 1878
2014
Q2 		$6.93M Sell
345,673
-45,344
-12% -$1.04M ﹤0.01% 2145
2014
Q1 		$10.6M Buy
391,017
+49,116
+14% +$1.3M ﹤0.01% 1870
2013
Q4 		$7.09M Buy
341,901
+65,447
+24% +$1.23M ﹤0.01% 2081
2013
Q3 		$5.03M Sell
276,454
-119,442
-30% -$2.16M ﹤0.01% 2243
2013
Q2 		$6.58M Buy
+395,896
New +$6.32M ﹤0.01% 2033

Other funds holding AUXL

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Bank of New York Mellon's AUXL Position: Q1 2015 in Review

Bank of New York Mellon sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 265,268 shares — an estimated $9.12M sold.

Bank of New York Mellon first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $10.6M in Q1 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • Bank of New York Mellon reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Bank of New York Mellon sold 265,268 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $9.12M.
  • Bank of New York Mellon first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Bank of New York Mellon's AUXILIUM PHARAMCEUTICALS INC position peaked at $10.6M in Q1 2014.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Bank of New York Mellon's 13F filing for Q1 2015, filed 13 May 2015.